Abstract: The disclosure relates to novel compounds and methods of use of the compounds to maintain the G?i2 protein in its inactive GDP-bound state. The disclosure describes the knockdown or inhibition of G?i2 negatively regulated migration of breast and ovarian cancer cell lines. The novel compounds inhibit the migratory behavior of PC3, DU145 and E006AA prostate cancer cell lines. Specifically, the novel compounds block the activation of G?i2 in oxytocin-stimulated prostate cancer PC3 cells and inhibits the migratory capability of DU145 cells overexpressing constitutively active form of G?i2, under basal and EGF-stimulated conditions.

Abstract: System and method for generating a display to create an artificial window, the method including displaying, on a display screen, a first signal received from a first source via a first input of the display screen, and emitting lighting on a bezel of the display screen or a display member around the bezel or on a border within the display screen while the first signal is displayed on the display screen.

Abstract: Provided are compositions and methods for increasing the production of steroid hormones in testes, ovaries, or adrenal glands in a subject in need thereof. Also provided are compositions and methods for inhibiting proliferation of ovarian, testicular, prostate gland, breast, and liver cancer cells.

Abstract: Provided are compositions and methods for increasing the production of steroid hormones in testes, ovaries, or adrenal glands in a subject in need thereof. Also provided are compositions and methods for inhibiting proliferation of ovarian, testicular, prostate gland, breast, and liver cancer cells.